Biotech News
TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results
ir.telabio.com2026-05-06 15:03 EST
MALVERN, Pa., March 10, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report fourth quarter and full year 2025 financial